Farmax India Limited reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2015. For the quarter, the company reported net sales/income from operations of INR 41.388 million against INR 59.33 million a year ago. Loss before tax was INR 50.587 million against INR 15.526 million a year ago. Net loss after tax & extraordinary items was INR 50.587 million against INR 15.526 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.09 against INR 0.04 a year ago.

For the nine months, the company reported net sales/income from operations of INR 146.913 million against INR 130.670 million a year ago. Loss before tax was INR 92.027 million against INR 66.955 million a year ago. Net loss after tax & extraordinary items was INR 92.027 million against INR 66.955 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.17 against INR 0.16 a year ago.